Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/20/2003WO2003095645A1 Assay for melanogenesis
11/20/2003WO2003095643A1 Method of inhibiting gene expression
11/20/2003WO2003095642A2 Polyepitopes and mini-genes for cancer treatment
11/20/2003WO2003095640A2 Transgenic rat as animal model for human huntingdon's disease
11/20/2003WO2003095639A1 Directed-selective screening : conception and production of active molecules that are evolutionary chaemeras
11/20/2003WO2003095638A1 Pectate lyase variants
11/20/2003WO2003095635A2 Nucleotide sequence coding for a mannitol 2-dehydrogenase and method for the production of d-mannitol
11/20/2003WO2003095628A2 Control of es cell self renewal and lineage specification, and medium therefor
11/20/2003WO2003095627A1 A modified yeast consuming l-arabinose
11/20/2003WO2003095615A2 Transgenic plants with a suppressed triterpene level
11/20/2003WO2003095614A2 Cytokine polypeptides
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095608A2 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith
11/20/2003WO2003095605A2 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors
11/20/2003WO2003095493A2 Toxin-related antibodies with antimicrobial and antiviral activity
11/20/2003WO2003095488A1 Chimeric antagonist anth1
11/20/2003WO2003095481A1 Streptococcal superantigens spe-l and spe-m
11/20/2003WO2003095480A2 Brachyspira hyodysenteriae vaccine
11/20/2003WO2003094973A1 Agent and method for transporting biologically active molecules in cells
11/20/2003WO2003094971A1 Cationic lipids for intracellular delivery of bioactive substances
11/20/2003WO2003094963A2 Methylated immunostimulatory oligonucleotides and methods of using the same
11/20/2003WO2003094859A2 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003WO2003094856A2 1l1rl-1 as a cardiovascular disease marker and therapeutic target
11/20/2003WO2003094849A2 Ferritin fusion proteins for use in vaccines and other applications
11/20/2003WO2003094836A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/20/2003WO2003094829A2 Pathogen vaccines and methods for using the same
11/20/2003WO2003094828A2 Cancer vaccines and methods of using the same
11/20/2003WO2003094610A1 Research models for the evaluation of retinopathy or microangiopathy and uses thereof
11/20/2003WO2003094600A1 Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content
11/20/2003WO2003081996A3 Non-human transgenic mammals carrying germile mutations in both the p53 andfos genes and their use as a disease model
11/20/2003WO2003074546A8 Streptavidin-binding peptide
11/20/2003WO2003073995A3 Dna vaccine against proliferating endothelial cells and methods of use thereof.
11/20/2003WO2003072702A3 Merhod for cloning and expression of mspa1i restriction endonuclease and mspa1i methylase in e. coli
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/20/2003WO2003066895A3 Quantitative methylation detection in dna samples
11/20/2003WO2003066865A3 Nucleic acid molecule for regulation of gene expression in plants
11/20/2003WO2003062383A3 In vivo gene transfer
11/20/2003WO2003055995A3 Lipase genes and proteins
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003052071A3 Intracellular generation of single-stranded dna
11/20/2003WO2003051927A3 Production of f(ab')2 fragments in mammalian cells
11/20/2003WO2003050504A3 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201
11/20/2003WO2003050287A3 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
11/20/2003WO2003048768A3 Protein arrays for allelic variants and uses thereof
11/20/2003WO2003046124A3 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
11/20/2003WO2003044172A3 Composition comprising and method of using angiopoietin-like protein 3 angptl3
11/20/2003WO2003042401A3 Novel chromophores/fluorophores and methods for using the same
11/20/2003WO2003042360A3 Antisense modulation of inhibitor-kappa b-r expression
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003041830A3 Macroporous gel, its preparation and its use
11/20/2003WO2003040344A3 Transcription factor stress-related polypeptides and methods of use in plants
11/20/2003WO2003040343A3 Polynucleotide and polypeptide sequences of canine cathepsin s
11/20/2003WO2003040334A3 Methods for the identification of inhibitors of 4-coumarate-coa ligase expression or activity in plants
11/20/2003WO2003040183A3 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
11/20/2003WO2003039459A3 Viral vector production methods and compositions
11/20/2003WO2003039458A3 TREATMENT OF HUMAN CANCER WITH ADENOVIRAL VECTOR EXPRESSING TNF-α
11/20/2003WO2003038110A3 7118, a human arginine n-methyltransferase family member and uses therefor
11/20/2003WO2003038093A3 Regulation of human l-serine dehydratase
11/20/2003WO2003035842A3 Hybridization control of sequence variation
11/20/2003WO2003031567A3 Precursor conversion screening methods
11/20/2003WO2003027306A3 Bgl3 beta-glucosidase and nucleic acids encoding the same
11/20/2003WO2003023041A3 Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use
11/20/2003WO2003023018A3 A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use
11/20/2003WO2003023004A3 Antisense modulation of fibroblast growth factor receptor 3 expression
11/20/2003WO2003022421A3 Microcolumn-platform based array for high-throughput analysis
11/20/2003WO2003021261A3 Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
11/20/2003WO2003020937A3 Rice regulatory sequences for gene expression in defined wheat tissue
11/20/2003WO2003020931A3 Sirna knockout assay method and constructs
11/20/2003WO2003020764A3 Modified factor ix
11/20/2003WO2003020756A3 Hybrid and tandem expression of neisserial proteins
11/20/2003WO2003020025A3 Nucleic acid compositions conferring insect control in plants
11/20/2003WO2003016551A3 Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof
11/20/2003WO2003016506A3 Secreted proteins
11/20/2003WO2003016468A3 Antagonistic anti-htnfsf13b human antibodies
11/20/2003WO2003014351A3 Stress-associated genetic products from ashbya gossypii
11/20/2003WO2003012093A3 Regulator of calcineurin
11/20/2003WO2003012062A3 Animal model with disrupted fgf14 gene
11/20/2003WO2003012054A3 Methods and compositions relating to improved lentiviral vector production systems
11/20/2003WO2003012050A3 Mitochondrial genome replenishment
11/20/2003WO2003011016A3 Genetically modified cows having reduced susceptibility to mad cow disease
11/20/2003WO2003011015A3 Methods for improving seed and grain characteristics
11/20/2003WO2003009816A3 Facile detection of polycythemia vera
11/20/2003WO2003008638A3 Sorting and immobilization system for nucleic acids using synthetic bidning systems
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003007884A3 Method and reagents for identifying gene targets for treating breast cancer
11/20/2003WO2003006659B1 Plant transcriptional repressor, proteic nuclear factors binding thereto, and uses thereof
11/20/2003WO2003006647A9 Allene oxide synthase and divinyl ether synthase from the cyp74-enzyme family isolated out of physcomitrella patens, the nucleotide sequences that code these synthases, and method for producing pathogen-resistant plants
11/20/2003WO2003006616A3 Pseudotyped adeno-associated viruses and uses thereof
11/20/2003WO2003006509A3 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor
11/20/2003WO2003004627B1 Novel human hepatoma lines, methods for obtaining same and uses thereof
11/20/2003WO2003004613A3 Novel pgc-1 isoforms and uses therefor
11/20/2003WO2003004088A3 Method of administration of a gene of interest to the heart and vasculature
11/20/2003WO2003004055A3 Nucleic acid adjuvants
11/20/2003WO2003002727A3 Hammerhead ribozyme specific for the stearoyl-acp desaturrase of different oleaginous plants
11/20/2003WO2003001901A3 Tagetes erecta marigolds with altered carotenoid compositions and ratios
11/20/2003WO2003000891A3 Protein-protein interactions in the inner ear
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2003000021A3 Pancam nucleic acids and polypeptides
11/20/2003WO2002103048A3 Real happy mapping
1 ... 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 ... 4023